X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1421) 1421
Publication (37) 37
Book Review (17) 17
Magazine Article (5) 5
Book Chapter (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1311) 1311
urokinase-type plasminogen activator - therapeutic use (770) 770
female (731) 731
male (728) 728
middle aged (582) 582
urokinase-type plasminogen activator - administration & dosage (503) 503
aged (466) 466
adult (403) 403
urokinase-type plasminogen activator - adverse effects (386) 386
urokinase (298) 298
thrombolytic therapy (282) 282
index medicus (275) 275
fibrinolytic agents - therapeutic use (271) 271
treatment outcome (268) 268
streptokinase - therapeutic use (219) 219
thrombosis - drug therapy (217) 217
animals (190) 190
thrombolytic therapy - adverse effects (187) 187
fibrinolytic agents - adverse effects (181) 181
fibrinolytic agents - administration & dosage (177) 177
peripheral vascular disease (169) 169
surgery (163) 163
thrombolytic therapy - methods (157) 157
time factors (152) 152
tissue plasminogen activator - therapeutic use (152) 152
retrospective studies (149) 149
aged, 80 and over (143) 143
thrombosis - etiology (141) 141
plasminogen activators - therapeutic use (137) 137
thrombolysis (135) 135
heparin - therapeutic use (133) 133
myocardial infarction - drug therapy (133) 133
therapy (127) 127
urokinase-type plasminogen activator - metabolism (122) 122
follow-up studies (117) 117
pulmonary embolism - drug therapy (115) 115
acute disease (114) 114
streptokinase - adverse effects (113) 113
thrombosis (112) 112
cardiac & cardiovascular systems (111) 111
recurrence (108) 108
adolescent (102) 102
fibrinolysis (98) 98
hemorrhage - chemically induced (97) 97
oncology (97) 97
prospective studies (96) 96
clinical neurology (94) 94
plasminogen activators - administration & dosage (93) 93
radiology, nuclear medicine & medical imaging (89) 89
risk factors (88) 88
streptokinase (88) 88
tissue plasminogen activator - adverse effects (87) 87
plasminogen-activator (85) 85
drug therapy, combination (84) 84
catheterization, central venous - adverse effects (83) 83
infusions, intra-arterial (82) 82
child (81) 81
infusions, intravenous (80) 80
management (80) 80
tissue plasminogen activator - administration & dosage (76) 76
combined modality therapy (75) 75
prognosis (72) 72
catheters, indwelling - adverse effects (70) 70
radiography (70) 70
urokinase-type plasminogen activator - genetics (70) 70
heparin - administration & dosage (68) 68
mice (67) 67
dose-response relationship, drug (66) 66
recombinant proteins - therapeutic use (66) 66
streptokinase - administration & dosage (66) 66
thrombophlebitis - drug therapy (66) 66
complications (64) 64
hematology (64) 64
urokinase-type plasminogen activator - pharmacology (64) 64
arterial occlusive diseases - drug therapy (61) 61
graft occlusion, vascular - drug therapy (60) 60
health aspects (60) 60
care and treatment (59) 59
heparin - adverse effects (59) 59
leg - blood supply (58) 58
tomography, x-ray computed (56) 56
anticoagulants - therapeutic use (55) 55
expression (55) 55
child, preschool (53) 53
vascular patency (52) 52
angiography (51) 51
drug therapy (51) 51
infant (51) 51
cancer (50) 50
medicine & public health (50) 50
coronary angiography (48) 48
plasminogen activators - adverse effects (47) 47
pediatrics (46) 46
thrombosis - diagnostic imaging (45) 45
tissue-plasminogen-activator (45) 45
trial (45) 45
heparin (44) 44
thrombosis - therapy (44) 44
analysis (43) 43
angioplasty (43) 43
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1236) 1236
German (51) 51
French (50) 50
Japanese (31) 31
Italian (20) 20
Chinese (11) 11
Spanish (11) 11
Russian (5) 5
Hungarian (4) 4
Polish (4) 4
Danish (2) 2
Dutch (2) 2
Hebrew (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Cochrane database of systematic reviews, ISSN 1469-493X, 2013, Volume 12, Issue 12, p. CD001099
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2001, Volume 93, Issue 12, pp. 913- - 9120
Journal Article
Stroke, ISSN 0039-2499, 01/2007, Volume 38, Issue 1, pp. 80 - 84
Journal Article
Cerebrovascular Diseases, ISSN 1015-9770, 01/2014, Volume 37, Issue 1, pp. 43 - 50
Background: The use of thrombolytics is frequently considered in patients with cerebral venous and dural sinus thrombosis (CVT) who deteriorate despite... 
Original Paper | Urokinase | Recombinant tissue plasminogen activator | Intravenous thrombolysis | Dural sinus thrombosis | Cerebral venous thrombosis | THERAPY | PLASMINOGEN-ACTIVATOR | PERIPHERAL VASCULAR DISEASE | OF-THE-LITERATURE | VEIN | HEPARIN | CLINICAL NEUROLOGY | Recombinant Proteins - therapeutic use | Intracranial Thrombosis - complications | Urokinase-Type Plasminogen Activator - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Child, Preschool | Male | Thrombophilia - epidemiology | Thrombophilia - complications | Tissue Plasminogen Activator - adverse effects | Young Adult | Fibrinolytic Agents - adverse effects | Child | Intracranial Hypertension - etiology | Cerebral Hemorrhage - etiology | Cerebral Hemorrhage - chemically induced | Streptokinase - adverse effects | Disease Susceptibility | Venous Thrombosis - drug therapy | Tissue Plasminogen Activator - administration & dosage | Sinus Thrombosis, Intracranial - mortality | Streptokinase - therapeutic use | Brain Damage, Chronic - etiology | Intracranial Thrombosis - mortality | Thrombolytic Therapy | Adolescent | Brain Damage, Chronic - epidemiology | Coma - etiology | Urokinase-Type Plasminogen Activator - adverse effects | Infant | Tissue Plasminogen Activator - therapeutic use | Recombinant Proteins - adverse effects | Venous Thrombosis - complications | Activities of Daily Living | Streptokinase - administration & dosage | Fibrinolytic Agents - therapeutic use | Adult | Female | Intracranial Thrombosis - drug therapy | Urokinase-Type Plasminogen Activator - administration & dosage | Venous Thrombosis - mortality | Cerebral Hemorrhage - mortality | Treatment Outcome | Cerebral Veins | Recombinant Proteins - administration & dosage | Aged | Fibrinolytic Agents - administration & dosage | Infusions, Intravenous | Sinus Thrombosis, Intracranial - drug therapy | Sinus Thrombosis, Intracranial - complications
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2003, Volume 41, Issue 4, pp. 653 - 658
Journal Article
Stroke, ISSN 0039-2499, 2002, Volume 33, Issue 3, pp. 717 - 724
Journal Article
American Journal of Neuroradiology, ISSN 0195-6108, 01/2007, Volume 28, Issue 1, pp. 159 - 163
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2002, Volume 40, Issue 9, pp. 1660 - 1667
OBJECTIVES: We sought to assess the efficacy and safety of thrombolytic therapy in patients with an acute pulmonary embolism (PE). BACKGROUND: Thrombolytic... 
MULTICENTER | STREPTOKINASE | CARDIAC & CARDIOVASCULAR SYSTEMS | LIMITATIONS | PLASMINOGEN-ACTIVATOR | ALTEPLASE | REGIMEN | RANDOMIZED CLINICAL-TRIALS | HEPARIN | STRENGTHS | UROKINASE | Studies | Heart attacks | Hospitals | Medical imaging | Embolisms | Mortality | Drug therapy | Hemorrhage | Veins & arteries
Journal Article
Stroke, ISSN 0039-2499, 2002, Volume 33, Issue 7, pp. 1821 - 1826
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2005, Volume 99, Issue 1, pp. 50 - 57
Journal Article